Glicogênio sintase quinase3B e proteína precursora do amilóide em plaquetas de indivíduos com comprometimento cognitivo leve e doença de Alzheimer / Glycogen synthase kinase 3B and amyloid precursor protein in adults platelets with cognitive impairment and Alzheimers disease

AUTOR(ES)

Carolina Akkari Torres

DATA DE PUBLICAÇÃO

2010

RESUMO

Alzheimers disease (AD) is a neurodegenerative disease characterized by progressive decline of memory and other cognitive functions, affecting mainly elderly. The abnormal metabolism of amyloid precursor protein (APP) and protein TAU hyperphosphorylation are cellular hallmarks of this disease. Glycogen synthase kinase 3B (GSK3B) is an enzyme highly expressed in the central nervous system and of great importance in the regulation of neuronal plasticity and also the mechanisms of cell survival. Studies have associated GSK3B with the mechanisms that lead to the formation of senile plaques and neurofibrillary tangles in AD. Given the difficulty to establish the precise clinical diagnosis of AD, especially in the early stages of the disease, identification of biomarkers is particularly important, especially in peripheral tissues. This work evaluated two candidate biochemical markers for AD, using two different preparations. We investigated the ratio between 130kDa and 110kDa APP fragments (APPr) and between phosphorylated and total GSK3B (phospho-GSK3B / total-GSK3B) in platelets of patients with AD and mild cognitive impairment (MCI), comparing their results with those from healthy older adults (controls). The expression of APP fragments and GSK3B was assessed by Western blot using specific antibodies. No statistically significant differences in APPr were found between the study groups (p=0.847). We found statistically significant differences in mean total GSK3B and GSK3B ratio across disgnostic groups (p=0.05 and p=0.06, respectively). APPr and GSK3B ratio were not correlated, but the latter parameter did correlate with the performance on memory tests, as shown by the CAMCOG sub-score. The present data indicate that platelet GSK3B ratio may indicate biological changes that occur in the MCI-AD continuum

ASSUNTO(S)

biological markers glicogênio sintase amyloid precursor protein marcadores biológicos plaquetas doença de alzheimer biomarkers glycogen synthase proteína precursora do amilóide biomarcadores alzheimer disease platelets

Documentos Relacionados

• Fosfolipase A2, fluidez de membrana e proteína precursora do amilóide em plaquetas na doença de Alzheimer e comprometimento cognitivo leve
• Serotonina e glicogênio sintase quinase 3B em plaqueta de pacientes idosos com transtorno depressivo maior: efeito do tratamento com sertralina
• The dementia rating scale (DRS) in the diagnosis of mild cognitive impairment and Alzheimer´s disease
• Apatia e funções executivas em pacientes com doença de Alzheimer leve e em indivíduos com comprometimento cognitivo leve amnéstico
• Mutações no gene da proteina precursora da B-amiloide em familias afetadas pelo mal de Alzheimer